Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
AstraZeneca
AstraZeneca
Karolinska Institutet
Stichting Hemato-Oncologie voor Volwassenen Nederland
University of Washington
Abramson Cancer Center at Penn Medicine
The Netherlands Cancer Institute
Celgene
University of Alberta
VitaMed Research LLC
National Cheng-Kung University Hospital
Insel Gruppe AG, University Hospital Bern
University of Washington
Centre Henri Becquerel